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Abstract
Background: The β-catenin link between membrane-bound cadherins and the actin cytoskeleton
regulates cell adhesion and consequently metastasis. Abnormal stabilisation of β-catenin enhances
its transcriptional activities. Factors affecting β-catenin's functions are important in understanding
metastatic diseases such as oesophageal squamous cell carcinoma (SCC).
Results: In human oesophageal SCCs β-catenin localises predominantly to the plasma membrane.
The presence of free β-catenin in the cytoplasm/nucleus was low. This indicates that β-catenin's
activities are skewed towards cell-cell adhesion in these oesophageal SCCs. Exposure to EGF or Li
alone, produced a slight increase in membrane concentrations but only Li induced β-catenin
stabilisation in the cytoplasm. In combination, EGF and Li decreased membrane-associated β-
catenin, concomitantly increasing cytoplasmic concentrations. Convergence of these signalling
pathways appears to induce a β-catenin shift from the membrane into the cytoplasm.
Conclusion: Therefore, although the adhesive role of β-catenin appears to be intact, exogenous
signals increase the stability of free β-catenin thereby reducing cell-cell adhesion in these tumours.
Background
β-catenin participates in two distinct functions in the cell.
Firstly, there is a structural involvement where it plays an
essential intermediary role in the adherens junctions by
linking the plasma membrane-bound cadherin proteins
to the α-catenin/actin cytoskeleton complex [1–3].
Through this central position β-catenin regulates intercel-
lular adhesion [2,4–6]. Since the adhesion complex is
thought to be a suppressor of invasion and metastasis in
many epithelial tumours, the expression of β-catenin, and
thus the regulation of intercellular adhesion, may be a
pivotal feature in the behaviour of epithelial cancer cells
[3,7–9]. Secondly, β-catenin is active is in the regulation
of gene transcription where a number of the genes affected
are important during development [10,11]. These same
genes however, are potentially oncogenic if overexpressed
in the differentiated adult cell, examples being cyclin D1,
c-myc, matrilysin and urokinase plasminogen activator receptor
[12–15].
Accumulation of free, unbound β-catenin in the cyto-
plasm has been shown to potentiate the translocation of
β-catenin into the nucleus, augmenting its transcriptional
activity [1,10,16,17]. The level of cytoplasmic β-catenin is
usually tightly regulated by a degradation complex com-
posed of glycogen synthase kinase (GSK)-3β, adenoma-
tous polyposis coli (APC) and axin which bind to, and
phosphorylate, β-catenin targeting it for ubiquitination
and 26S proteasomal degradation [1,17]. Deregulation of
cytoplasmic β-catenin correlates with the development of
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a number of adenocarcinomas and melanomas by muta-
tion of the APC gene, or of the β-catenin gene CTNNB1
[18–20]. However, stabilisation of free β-catenin by such
mutations is not a feature of oesophageal SCCs [21,22].
A number of signalling pathways, such as those induced
by growth factors and Wnt, impinge on β-catenin's struc-
tural and signalling roles. Epidermal growth factor (EGF)
activity has been linked to changes in cell morphology,
such as plasma membrane ruffling and cell rounding,
both of which are required for cell migration and division
[5,23,24]. EGF receptors (EGFR) concentrate at the
plasma membrane with the cadherins, and alter adhesion
by disrupting the association between α– and β-catenin
through tyrosine phosphorylation of the latter [2,5,23–
26]. EGFR is also thought to inactivate GSK-3β via its acti-
vation of the MAPK pathway, which in turn activates the
GSK-3β inhibitor p90rsk[27]. Thus, a potentially impor-
tant outcome of EGF signalling is the accumulation of sta-
bilised cytoplasmic β-catenin.
Wnt activates a signalling cascade which inhibits the GSK-
3β/APC/axin degradation complex, stabilising cytoplas-
mic β-catenin and augmenting its transcriptional activities
[10,13]. This stabilising effect of the Wnt signal pathway
has been implicated in the development of a number of
cancers examples being colon and ovarian cancers [28].
Wnt-induced stabilisation of cytoplasmic β-catenin can be
simulated by lithium (Li) which mimics wnt by inhibiting
the serine kinase activity of GSK-3β [29,30].
A question that remains to be addressed is how do EGF
signals, and a Wnt-like stabilisation of β-catenin, affect the
balance between plasma membrane-associated β-catenin
and that found free in the cytoplasm? Chen et al. [30]
showed that growth factors, in particular EGF, enhanced
Li-induced accumulation of free β-catenin in C57MG
mouse mammary epithelial cells and 293-human trans-
formed embryonal epithelial kidney cells, most probably
by activating a distinct pathway involving the 12-O-tetra-
decanoylphobol-13-acetate (TPA)-sensitive protein
kinase C (PKC).
Oesophageal SCC has a poor prognosis and is among the
leading causes of cancer deaths worldwide [31–36]. The
incidence of oesophageal SCC is especially high in regions
of South Africa, China, Iran, Uruguay, France and Italy
[35,36]. Metastasis is of particular importance in oesopha-
geal SCCs as the majority of patients present with
advanced metastases [36]. In addition, recurrence of the
disease, after tissue resection, occurs in nearly half of all
patients due to the presence of micro-metastases [37],
drastically reducing the 5-year survival rates [36].
The expression of β-catenin present at the plasma mem-
brane has been shown to be an important reflection of the
state of intercellular adhesion and thus metastasis. This
has been well documented in the diffuse human gastric
signet ring carcinoma cell lines HSC-39 and HSC-40A [7].
In addition, colorectal cancers have also been shown to
display a reduced expression of β-catenin [2]. However,
this is yet to be elucidated for oesophageal SCCs. In addi-
tion, the effect of stabilisation of free β-catenin on its
adhesive function is not understood. Thus, the intracellu-
lar distribution of the protein to the membrane or free in
the cytoplasm or nucleus will also indicate its functioning
and possible role β-catenin may play in the invasion/
metastasis of this type of tumour.
Results
β-catenin co-localises with E-cadherin at the plasma 
membrane in oesophageal SCC
In epithelia, β-catenin normally localises immediately
below the plasma membrane in association with the cad-
herins that are involved in cell-cell adhesion [38]. Exami-
nation of the oesophageal SCC cell lines showed that E-
cadherin was concentrated at the plasma membrane cor-
responding to points of cell-cell contact, but was weak or
absent at contact free edges in the oesophageal SCC cell
lines, giving the typical "cobblestone" appearance of
squamous epithelia (Figure 1a). A similar pattern was
noted for β-catenin under standard in vitro conditions
(Figure 1b), suggesting that the protein co-localises with
E-cadherin just below the plasma membrane. This was
further confirmed by the strong presence of β-catenin in
the membrane fraction of the standard extracts from all
the oesophageal SCCs (Western blot, Figure 2a).
The presence of β-catenin in the cytoplasm and nucleus
has been associated with aberrant gene transcription and
cancer progression. The oesophageal SCCs however,
under standard conditions, did not display cytoplasmic or
nuclear "staining" (Figure 1b) and western blotting only
exposed extremely faint bands in the free fraction of three
of the five cell lines (WHCO3, WHCO5 and SNO; Figure
2b). The validity of this assessment was confirmed by the
use of a control cell line, CACO-2. The CACO-2 colorectal
cell line has constitutively active Wnt signalling, as well as
mutations in the APC gene, which lead to the stabilisation
of free β-catenin [19,39]. CACO-2 cells displayed greatly
enhanced nuclear staining with concomitantly reduced
plasma membrane staining (Figure 1c), while a strong
band was exposed by western blotting of the free fraction
of this cell line (Figure 2b). Thus, β-catenin is predomi-
nantly present at the plasma membrane, in oesophageal
SCC cells, while constitutive stabilisation of cytoplasmic
β-catenin and thus augmentation of its nuclear activities
does not appear to be a factor typical of this type of
tumour.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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β-catenin and E-cadherin localisation by indirect immunofluorescence Figure 1
β-catenin and E-cadherin localisation by indirect immunofluorescence. a) E-cadherin and b) β-catenin in the 
WHCO5 cell line. β-catenin localises at points of cell-cell adhesion (indicated by the yellow arrows), but is absent from the con-
tact free edges (blue arrow). c) CACO-2 (control) displays nuclear localisation of β-catenin (white arrow), with low levels 
present at the plasma membrane (yellow arrow). 400× magnification (FITC excitation 490, emission 525)
a)
b)
c)
a)
b)
c)Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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Oesophageal SCCs express similar levels of total β-catenin 
under standard in vitro conditions
The level of expression of the adhesion proteins may be an
important indicator of the level of adhesion that is occur-
ring between cells. Reduced levels of β-catenin expression
have been associated with the attenuation of adhesion
and increased metastasis in colorectal cancers and 33% of
other colon cancers [2]. Thus, the total concentration of β-
catenin synthesised by oesophageal SCCs was measured
by a modified RIA. Although WHCO3 and SNO cell lines
appeared to synthesise less β-catenin than the other three
lines, comparisons of the levels expressed indicated that
the level of β-catenin expressed did not differ significantly
between the cell lines (two-way ANOVA followed by a
Tukey's HSD test, F(4,42) = 1.09; p = 0.37; Figure 3).
Although the sensitivity of the RIA employed is useful in
quantifying the total cellular β-catenin levels, it does not
provide information regarding the distribution of the pro-
tein within the cell. Thus, the concentration of membrane
and free β-catenin was semi-quantitatively assessed by
laser densitometry of the western blots of β-catenin from
the membrane and the free fractions. It was established
that the membrane levels of β-catenin vary considerably
across the five oesophageal SCC lines with WHCO1
expressing the lowest level (26%) and WHCO6 expressing
Western blot analyses of oesophageal SCC and CACO-2 cell extracts Figure 2
Western blot analyses of oesophageal SCC and CACO-2 cell extracts. 5 µg of protein from a) the membrane and b) 
the cytoplasmic/nuclear (free) cellular fractions were separated on SDS-PAGE and blotted specifically for β-catenin. Lanes 1–6 
represent WHCO1, WHCO3, WHCO5, WHCO6, SNO and CACO-2 cell lines, respectively. a) The presence of β-catenin 
was identified in the membrane fractions of all cell lines (94 kD, black arrow). An 80 kD band was also exposed (red arrow) pre-
viously reported as a partial degradation product [22,57]. b) CACO-2 cell line, possessing stabilised cytoplasmic β-catenin [39], 
exhibits a strong β-catenin band in the free fraction (black arrow). This is in sharp contrast to extremely low free β-catenin con-
centrations in the oesophageal SCCs.
a)
b)Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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the highest level (100%) (Figure 4). This suggests that the
level of adhesion may differ between the five-oesophageal
SCC cell lines. The free levels of β-catenin were extremely
low (0–3%), in sharp contrast to the CACO-2 concentra-
tion (61%), indicating that the free β-catenin in the
oesophageal SCC is not stabilised in the cytoplasm as in
the CACO-2 cell line.
EGF and Li synergistically induce a shift of β-catenin from 
the membrane into the cytoplasm
Short exposure to EGF (15 minutes) alone caused the
oesophageal SCC cell lines to alter their cellular morphol-
ogy from the typical epithelial cobblestone shape to a
round, sometimes fibroblastic, morphology. These EGF
induced morphological changes returned to normal after
4 hours. Such a change of cell morphology is indicative of
cellular migration and parallels previous reports showing
EGF induced membrane ruffling within 5 minutes of
exposure followed by cell rounding and retraction from
the substratum [5,23,24]. Although the oesophageal cells
appeared to display a drop in β-catenin levels in the first
hour of EGF exposure, ANCOVA revealed that these
changes within each cell line, over the 24 hour period,
were not significant (F(7,205) = 1.72; p = 0.11; Figure 5).
This indicates that EGF treatment does not lead to a
change in the level of β-catenin expression in the oesopha-
geal cells over time. It is worth noting that, under EGF
treatment, the concentration of β-catenin differed signifi-
cantly between the cell lines (ANCOVA analysis, F(4,208) =
8.13; p < 0.001), with WHCO3 and WHCO5 differing sig-
nificantly from both WHCO6 (p = 0.016 and p = 0.014,
respectively) and SNO (p < 0.001 in both cases) cells
(Tukey's HSD analysis).
Densitometric analysis of the β-catenin levels under EGF
treatment (3 hours) alone showed that membrane levels
increased slightly from standard levels, but was margin-
ally reduced in the free fraction (Figure 6). However, the
localisation of β-catenin (indirect immunofluorescence)
did not visually alter under EGF treatment.
Similarly, membrane-associated β-catenin levels
increased in response to Li stimulation (Figure 6). How-
ever, in contrast to EGF stimulation, the free levels of β-
catenin increased dramatically at 3 hours possibly demon-
strating the inhibitory action of Li on GSK-3β. However,
this inhibition appeared to be short lived, as after 12
Total β-catenin expression in oesophageal SCCs Figure 3
Total β-catenin expression in oesophageal SCCs. β-
catenin levels were assessed by a modified RIA. β-catenin 
expression (blue) does not differ significantly between the 
five moderately differentiated oesophageal SCC cell lines 
(F(4,42) = 1.09; p = 0.37). However, it should be noted that 
WHCO3 and SNO display slightly lower levels of the protein 
than the other three cell lines. The control (yellow) indicates 
non-specific binding of 125I-protein A is statistically negligible 
(F(1,42) = 60.69; p < 0.001) and no interaction occurred 
between the experimental and control groups (F(4,42) = 0.79; 
p = 0.54).
Analysis of β-catenin expression in membrane and free  fractions Figure 4
Analysis of β-catenin expression in membrane and 
free fractions. Membrane-associated β-catenin (blue), and 
free (yellow), fractions were analysed semi-quantitatively by 
laser densitometry of the western blots. Levels are repre-
sented as a percentage of the maximum per 5 µg of protein 
from each fraction. The membrane levels of β-catenin varied 
over a range of 70%. The CACO-2 control shows that the 
free component of β-catenin is substantially increased and is 
higher than its membrane component. The level of free β-
catenin in the oesophageal SCC cell lines is low (WHCO3, 
WHCO5 and SNO) to negligible (WHCO1 and WHCO6). 
Note: the nature of this analysis does not lend itself to the 
inclusion of error bars.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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hours of exposure free β-catenin was no longer detected.
This effect of Li on the cytoplasmic component was only
visually obvious in WHCO5 in which an increase in cyto-
plasmic staining was noted (Figure 7a).
Surprisingly, however, the effect of simultaneous EGF and
Li stimulation produced a marked decreased the level of
membrane-associate β-catenin concentrations compared
with the standard (Figure 6). The free component of the
oesophageal SCCs was found to increase dramatically
(over 8-fold in WHCO3). This enhancing effect, of EGF
stimulation on Li-induced accumulation of cytoplasmic
β-catenin, parallels the results obtained for C57MG and
293-cells [30]. By 12 hours however, no free β-catenin was
detected in the oesophageal SCCs. This was further illus-
trated in the SNO and WHCO5 cell lines in which cyto-
plasmic staining was noted in both, and nuclear staining
in the latter (3 hours of stimulation) which returned to
standard patterns after 12 hours (Figure 7b).
Discussion
β-catenin is primarily involved in adhesion in oesophageal 
SCCs
The central role played by β-catenin in linking the plasma
membrane bound cadherin proteins to the cytoskeleton
has implicated this protein in the regulation of the
strength of adhesion [5,6]. Reduction of β-catenin at cell-
cell contacts is associated with the progression and inva-
sion of many tumours [1,9]. In addition, deregulation of
the cytoplasmic levels of this protein has been linked to
the progression of many tumours such as colorectal aden-
ocarcinomas [1,10,16,17]. As both the adhesive and tran-
scriptional roles of β-catenin have the potential for
enhancing the development and spread of a tumour,
understanding the expression and functioning of β-cat-
enin may be imperative for understanding the dynamics
of a particular tumour type. This study focused on the
expression of β-catenin in oesophageal SCC cell lines, and
whether the distribution of the β-catenin protein in these
lines is useful in understanding the subsequent behaviour
of this disease.
The inability of components of the adhesion junction to
physically associate can result in loss of adhesion and tis-
sue compaction. Truncations of the adhesion proteins can
prevent these interactions from occurring. For example,
breast, prostate, gynaecological and diffuse-type gastric
cancers produce truncated E-cadherin proteins that result
in abnormal cell-cell adhesion as its association with β-
catenin is abrogated [8,9,40–42]. This study show that, in
Effect of EGF on the level of β-catenin expression Figure 5
Effect of EGF on the level of β-catenin expression. The concentration of β-catenin (CPM/105 cells). Although β-catenin 
concentrations tended to decrease initially (within the first hour) when exposed to EGF, no significant difference occurred 
between β-catenin levels within each cell line over the 24 hour time course of EGF treatment (F(7,205) = 1.72; p = 0.11). A signif-
icant difference however, was identified between the cell lines (F(4,208) = 8.13; p < 0.001), with WHCO3 differing from WHCO6 
(p = 0.02) and SNO (p < 0.001), and WHCO5 from WHCO6 (p = 0.01) and SNO (p < 0.001).Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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Effect of EGF and/or Li on the subcellular distribution of β-catenin Figure 6
Effect of EGF and/or Li on the subcellular distribution of β-catenin. The level of β-catenin expressed under EGF and/
or Lithium stimulation are expressed as a fold increase relative to a) the membrane standard (= 1, indicated by the red line) for 
the membrane fractions, and b) to the SNO standard (= 1, indicated by the red line) for the free fractions. a) In general, EGF 
and Li alone slightly increase the levels of β-catenin. Combined EGF and Li signalling results in a decline of membrane-associ-
ated β-catenin. b) Little or no β-catenin was detected in the free fractions after exposure to EGF (3 hours), Li (12 and 24 
hours), or EGF and Li (12 and 24 hours). Li stimulation (3 hours) increased free levels in WHCO1, WHCO3 and WHCO5. 
Concurrent EGF and Li treatment (3 hours) caused free β-catenin to increase substantially in all cell lines, most notably in 
WHCO3 (over 8-fold).
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oesophageal SCCs, the majority of β-catenin localises to
points of cell-cell contact at the plasma membrane corre-
sponding to the localisation of E-cadherin in these cell
lines. This intimates that the association between β-cat-
enin and E-cadherin is not compromised in this type of
cancer. Thus, reduced adhesion due to truncation of E-
cadherin (or β-catenin) is unlikely.
Reduced expression of β-catenin has been associated with
the attenuation of adhesion and increased metastasis [2].
The total levels of β-catenin detected by radioimmu-
noassay showed that the oesophageal SCC cell lines did
not differ significantly from each other. However, the con-
centration of β-catenin associated with the membrane dis-
played large differences between the cell lines, which may
indicate inconsistencies in the level of adhesion between
the oesophageal lines.
Deregulation and stabilisation of β-catenin in the cyto-
plasm has been associated with the progression of a
number of cancers [28]. These cancers often contain
mutations of either the APC gene or of the β-catenin gene
(CTNNB1) itself, which impedes the targeting phosphor-
ylation of β-catenin, freeing the protein from ubiquitina-
tion and its subsequent degradation [19,20,43]. However,
such mutation of APC and CTNNB1 are rare in oesopha-
geal SCCs [21,22]. The results presented here provide an
alternative to the mutational explanation in that the
oesophageal SCC cell lines express extremely low levels of
free β-catenin in comparison to a line with constitutively
active Wnt signalling (CACO-2, [39]). Thus, constitutive
stabilisation of cytoplasmic β-catenin is unlikely to be a
contributing factor in oesophageal SCC with its function
being more skewed towards cell-cell adhesion.
The effect of exogenous signals, EGF and lithium, on the 
functions of β-catenin
It has long been known that EGF signalling affects inter-
cellular adhesion. Shiozaki et al. [23] described
modifications to cellular morphology in poorly differen-
tiated oesophageal SCCs in response to EGF stimulation
that result in decreased cell-cell adhesion. We similarly
demonstrated this effect in the South African WHCO
series of oesophageal SCCs within 15 minutes of exposure
(results not shown). Since β-catenin and E-cadherin colo-
calise, a plausible explanation is that the activated EGFR
phosphorylates  β-catenin thereby disrupting the bond
between β-catenin and α-catenin, while maintaining its
attachment to E-cadherin [5,25]. Thus, cadherin's link to
the actin cytoskeleton is severed and cell adhesion is
reduced.
EGF signalling alone is insufficient to stabilise free β-cat-
enin in oesophageal SCCs as no increase in the free frac-
tion was detected in any of the oesophageal cell lines used
in this study (see also Mizushima et al. [44]). In addition,
the slight decrease in the total level of β-catenin expressed
in all the cell lines within the first hour of exposure,
suggests that EGF stimulation results in β-catenin being
released into the cytoplasm where it becomes degraded.
The major effect of the Wnt signalling pathway is the sta-
bilisation of β-catenin in the cytoplasm thereby augment-
ing its transcriptional activity. Constitutive stabilisation of
cytoplasmic β-catenin, such as by mutation of APC and
CTNNB1, does not occur in human oesophageal SCCs
[21,22]. However, Wnt signalling has many other effects
on cellular activities such as proliferation, polarity,
β-catenin localisation following Li, and EGF + Li stimulation Figure 7
β-catenin localisation following Li, and EGF + Li stim-
ulation. Under all EGF and/or Li treatments β-catenin 
remained intense at the membrane (see white arrows). a) Li 
alone, (3 hrs) induced a cytoplasmic β-catenin localisation in 
WHCO5 (blue arrows). b) EGF and Li together, (3 hrs) 
induced β-catenin to locate to the cytoplasm and nucleus 
(yellow arrow) in WHCO5 (see results for details). 400× mag-
nification. (FITC excitation 490; emission 525).
a)
b)Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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differentiation and importantly, migration [13,45,46].
Lithium, a non-competitive inhibitor of GSK-3β and
mimic of Wnt signalling [29,30], effectively stabilised free
β-catenin in the oesophageal SCCs as shown by the
increase of free β-catenin in response to Li exposure (3
hours). However, Li effects are short-lived as β-catenin
was no longer detected in the free fraction after 12 hours,
presumably as the degradation complex was able to
resume its activities and control β-catenin levels.
The elevation of β-catenin at the plasma membrane noted
in the oesophageal SCCs, in response to Li stimulation,
may be due to E-cadherin sequestering the excess free β-
catenin induced by Li signals [47]. β-catenin stabilisation
by a Wnt-type signal, therefore, does not reduce its adhe-
sive role which would be expected for increased cell
mobility. Rather, it appears to increase the levels of β-cat-
enin involved in adhesion. This was similarly demon-
strated by Hinck et al. [48], in the C57MG mouse
mammary epithelial cell line, that wnt-1 activity stabilises
the contact between E-cadherin and β-catenin and conse-
quently increases the strength of intercellular adhesion.
This strongly indicates that stabilisation of β-catenin by
Wnt signalling may be more important in the formation
of cellular adhesion rather than its dissociation. This then
could be a crucial factor in the establishment of a tumour
cell in distal tissue after metastasis.
EGF signalling augmented the Li-induced accumulation
of stable free β-catenin in all five of the oesophageal SCCs
(see also Chen et al. [30]). Interestingly, however, as the
free level of β-catenin increased in response to EGF and Li
stimulation, the concentration of plasma membrane-
associated β-catenin decreased. Thus, it is proposed that
the augmentation of the Li-induced stabilisation of β-cat-
enin by EGF is due to the protein shifting from its plasma
membrane localisation into the cytoplasm. Chen et al.
[30] identified an EGF activation of PKCα but were una-
ble to identify the target of this serine kinase. Baulida et
al. [49] reported that activation of PKCα in normal intes-
tinal cell lines, results in a shift of the β-catenin from
plasma membrane to the cytoplasm and nucleus. Thus we
suggest that the target of EGF activated PKCα is the adhe-
sion complex itself.
The question remains as to why stabilisation is necessary
to effect the growth factor-induced shift. Overexpression
of cytoplasmic β-catenin is able to overcome the tension
between cellular adhesion and apoptosis [42,50]. Addi-
tionally, APC and GSK-3β function as pro-apoptotic sig-
nals [51]. Thus, inhibition of GSK-3β and the resulting
overexpression of β-catenin, may be necessary for the cell
to survive the loss of adhesion required for metastasis.
Conclusions
This study has demonstrated the importance of β-catenin
in cell-cell adhesion in moderately differentiated human
oesophageal SCCs and how the EGF and Wnt signalling
pathways impinge on the cellular distribution, possibly
enhancing the development of this type of tumour. The
demonstration of the redistribution of the protein
between its structural activities and its role in gene regula-
tion, through stimulation by the exogenous factors EGF
and Li, highlighted the delicate balance between mem-
brane-associated  β-catenin and its stabilisation in the
cytoplasm. Thus, from the results presented here, the
ostensibly distinct functions of β-catenin i.e. adhesion vs.
transcriptional regulation, are shown in reality to be inex-
tricably linked. There remains, however, many questions
still to be answered before a more complete picture can be
generated of the role of β-catenin in human oesophageal
SCC.
Methods
Cell lines and culture
Five human oesophageal squamous cell carcinoma cell
lines WHCO1, WHCO3, WHCO5, WHCO6 [52] and
SNO [53] (Passage numbers 32, 11, 17, 19 and indetermi-
nate, respectively), derived from moderately differenti-
ated tumour resections from patients presenting with
metastatic disease and the human colon adenocarcinoma
CACO-2 cell line were maintained in Dulbecco's Modi-
fied Eagles Medium (DMEM) supplemented with Hams
F12 (3:1) and 10% foetal calf serum, at 37°C in a 5% CO2
atmosphere. All cell lines were mycoplasma free according
to the MycoFluor Mycoplasma Detection Kit (Molecular
Probes, USA).
Antibodies
Polyclonal rabbit anti-human β-catenin (Sigma, USA),
monoclonal mouse anti-human E-cadherin (HECD-1,
R&D Systems, UK), Fluoroscine isothiocyanate (FITC)-
conjugated anti-rabbit (Chappel, USA), Sheep anti-mouse
IgG FITC conjugate (Serotec, SA), Polyclonal horseradish
peroxidase (HRP)-bound anti-rabbit (Separations, SA),
125I Protein A (ICN Pharmaceuticals, USA).
Treatments
Cell cultures were treated with EGF (10 ng/ml) for 3
hours, or with Li (10 mM) for 3, 12 and 24 hours, or with
a combination of EGF (10 ng/ml) and Li (10 mM) for 3,
12 and 24 hours.
Indirect immunofluorescence
Cells grown on glass coverslips were fixed with 4% para-
formaldehyde and permeabilised with 0.25% Triton X-
100. Exposure to primary antibody (either E-cadherin,
1:200 or β-catenin, 1:300) for 1.5 hours followed by a PBS
rinse and incubation with the appropriate fluoroscineCancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/13
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isothiocyanate (FITC)-conjugated secondary antibody
(1:500) for 1.5 hours. Cells were viewed at 400× magnifi-
cation under a Zeiss LSM 410 confocal microscope.
Immunoblotting
Membrane and cytoplasmic/nuclear (which contains the
essentially "free" component of β-catenin) fractions of
oesophageal SCCs were prepared following the protocol
described by Chen et al. [30]. Cultures (standard and
treated) were rinsed with PBS containing phenyl-methyl-
sulphonyl fluoride (PMSF)/Aprotinin solution and
scraped into the same solution. Cells were centrifuged
(500 × g) and the pellet was homogenised in a hypotonic
buffer [20 mM Tris.HCl, pH 7.4–7.5/25 mM NaF/1 mM
EDTA/20 mM PMSF (5 µl/ml)/Aprotinin (10 µl/ml)/Pep-
statin A (1 µl/ml)/Leupeptin (0.5 µl/ml)]. The lysate was
subjected to ultra-centrifugation (100 000 × g) for 30 min-
utes at 4°C. The resultant supernatant contained the cyto-
plasmic/nuclear material, while the pellet contained the
insoluble membrane fraction, which was dissolved into a
0.1% sodium dodecyl sulphate (SDS) in 20 mM Tris.HCl
(pH 7.4) solution. Total protein content was determined
according to Bramhall et al. [54].
5 µg of protein from each fraction was resolved on 10%
SDS-polyarcylamide gel electrophoresis [55]. Western
blots were blocked with a casein-based blocking buffer (1
hour), incubated in polyclonal anti-β-catenin antibody (2
hours), followed by incubation in HRP-bound anti-rabbit
secondary antibody (1 hour). Detection was carried out
with the SuperSignal® West Pico Chemiluminescent Sub-
strate kit (Pierce, USA).
Radioimmunoassay
A modified radioimmunoassay [56] was used to quantify
the levels of β-catenin present in the oesophageal SCC cell
lines under standard in vitro conditions and following
exposure to 10 ng/ml EGF. Triplicate cultures were fixed
with 4% paraformaldehyde [17], permeabilised with
0.25% Triton X-100 and blocked with a casein-based
blocking buffer. Cells were incubated for 1.5 hours with
the primary anti-β-catenin antibody (1:300) and subse-
quently exposed to 125I-Protein A (1.1 µCi/ml) for 1 hour.
Controls were incubated in PBS. Specific antibody bind-
ing to β-catenin was determined (Packard Cobra Auto-
Gamma counter) and recorded as counts per minute or
CPM. The experiment was repeated 3 times and results of
cells cultured under standard conditions were analysed by
a two-way ANOVA and a Tukey's HSD test, while cells
exposed to EGF were analysed by an ANCOVA and
Tukey's HSD (Statistica 5.1).
Laser densitometry
Laser densitometric analysis (LKB 2202 UltraScan Laser
Densitometer) of the western blots was used for semi-
quantitative comparison of the levels of the various frac-
tions. The area under the peak for each sample was used
as a basis for comparison. Expression levels were either
represented as a percentage of the maximum per 5 µg of
protein, or as a fold increase (or decrease) with respect to
the standard expression of β-catenin in the oesophageal
SCC cell lines (= 1).
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GSK-3β, glycogen synthase kinase-3β; APC, adenomatous
polyposis coli; SCC, squamous cell carcinoma; EGF, epi-
dermal growth factor, EGFR, EGF receptor; Li, lithium;
PKC, protein kinase C; CPM, counts per minute.
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